Anika Therapeutics Inc. (ANIK 7.18, +2.12, +41.84%) shares surged 55%. The firm said it has received approval from Canadian health regulators for Monovisc, its single-injection viscosupplement for the treatment of osteoarthritis of the knee.
UBS AG (UBS 16.50, +1.06, +6.87%) shares rose 5% after the Swiss government said late Wednesday that it will sell its stake in the bank. The Swiss Confederation will convert all its UBS mandatory convertible notes due 2011, worth 6 billion Swiss francs ($5.6 billion) into UBS shares, the bank said in a statement on its Website. Separately, UBS will hand over the names of 4,450 clients to the U.S., in a tax settlement with the Internal Revenue Service. See full story.
EDAP TMS SA (EDAP 4.34, +0.14, +3.33%) shares jumped 23%. On Wednesday, the French firm said the U.S. Food and Drug Administration gave marketing clearance for its Sonolith I-Sys therapeutic ultrasound device.
